Informatie:
Fout:
ID
12654
Beschrijving
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00130195
Link
https://clinicaltrials.gov/show/NCT00130195
Trefwoorden
Versies (1)
- 08-12-15 08-12-15 -
Geüploaded op
8 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Lymphoblastic Leukemia NCT00130195
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
age, hct
Item
adult subjects with a hct of less than 30 or pediatric subjects less than 25 will be excluded.
boolean
C0001779 (UMLS CUI [1])
C0518014 (UMLS CUI [2])
C0518014 (UMLS CUI [2])
age
Item
children with hcv infection younger than 2 years of age will be excluded.
boolean
C0001779 (UMLS CUI [1])
age
Item
unaffected healthy volunteers who are minors are not eligible for this study.
boolean
C0001779 (UMLS CUI [1])